BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 21190450)

  • 1. Improved mobilization of the CD34(+) and CD133(+) bone marrow-derived circulating progenitor cells by freshly isolated intracoronary bone marrow cell transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Adolph E; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cells Dev; 2011 Sep; 20(9):1491-501. PubMed ID: 21190450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced mobilization of the bone marrow-derived circulating progenitor cells by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction.
    Turan RG; Bozdag-T I; Turan CH; Ortak J; Akin I; Kische S; Schneider H; Rauchhaus M; Rehders TC; Kleinfeldt T; Belu C; Amen S; Hermann T; Yokus S; Brehm M; Steiner S; Chatterjee T; Sahin K; Nienaber CA; Ince H
    J Cell Mol Med; 2012 Apr; 16(4):852-64. PubMed ID: 21707914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved functional activity of bone marrow derived circulating progenitor cells after intra coronary freshly isolated bone marrow cells transplantation in patients with ischemic heart disease.
    Turan RG; Bozdag-T I; Ortak J; Kische S; Akin I; Schneider H; Turan CH; Rehders TC; Rauchhaus M; Kleinfeldt T; Belu C; Brehm M; Yokus S; Steiner S; Sahin K; Nienaber CA; Ince H
    Stem Cell Rev Rep; 2011 Sep; 7(3):646-56. PubMed ID: 21188654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
    Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
    Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra coronary freshly isolated bone marrow cells transplantation improve cardiac function in patients with ischemic heart disease.
    Bozdag-Turan I; Turan RG; Ludovicy S; Akin I; Kische S; Schneider H; Rehders TC; Turan CH; Arsoy NS; Hermann T; Paranskaya L; Ortak J; Kohlschein P; Bastian M; Sahin K; Nienaber CA; Ince H
    BMC Res Notes; 2012 Apr; 5():195. PubMed ID: 22534049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired mobilization of CD133(+) bone marrow-derived circulating progenitor cells with an increased number of diseased coronary arteries in ischemic heart disease patients with diabetes.
    Turan RG; Turan CH; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Kleinfeldt T; Rehders TC; Rauchhaus M; Adolph E; Amen S; Hermann T; Yokus S; Brehm M; Steiner S; Sahin K; Nienaber CA; Ince H
    Circ J; 2011; 75(11):2635-41. PubMed ID: 21828932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between the frequency of CD34⁺ bone marrow derived circulating progenitor cells and the number of diseased coronary arteries in patients with myocardial ischemia and diabetes.
    Bozdag-Turan I; Turan RG; Turan CH; Ludovicy S; Akin I; Kische S; Arsoy NS; Schneider H; Ortak J; Rehders T; Hermann T; Paranskaya L; Kohlschein P; Bastian M; Ulus AT; Sahin K; Ince H; Nienaber CA
    Cardiovasc Diabetol; 2011 Nov; 10():107. PubMed ID: 22118372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracoronary infusion of CD133+ and CD133-CD34+ selected autologous bone marrow progenitor cells in patients with chronic ischemic cardiomyopathy: cell isolation, adherence to the infarcted area, and body distribution.
    Goussetis E; Manginas A; Koutelou M; Peristeri I; Theodosaki M; Kollaros N; Leontiadis E; Theodorakos A; Paterakis G; Karatasakis G; Cokkinos DV; Graphakos S
    Stem Cells; 2006 Oct; 24(10):2279-83. PubMed ID: 16794269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of cardiac function by intracoronary freshly isolated bone marrow cells transplantation in patients with acute myocardial infarction.
    Turan RG; Bozdag-Turan I; Ortak J; Akin I; Kische S; Schneider H; Rehders TC; Turan CH; Rauchhaus M; Kleinfeldt T; Chatterjee T; Sahin K; Nienaber CA; Ince H
    Circ J; 2011; 75(3):683-91. PubMed ID: 21266786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pilot study to evaluate the safety and feasibility of intracoronary CD133(+) and CD133(-) CD34(+) cell therapy in patients with nonviable anterior myocardial infarction.
    Manginas A; Goussetis E; Koutelou M; Karatasakis G; Peristeri I; Theodorakos A; Leontiadis E; Plessas N; Theodosaki M; Graphakos S; Cokkinos DV
    Catheter Cardiovasc Interv; 2007 May; 69(6):773-81. PubMed ID: 17394248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.
    Nasseri BA; Ebell W; Dandel M; Kukucka M; Gebker R; Doltra A; Knosalla C; Choi YH; Hetzer R; Stamm C
    Eur Heart J; 2014 May; 35(19):1263-74. PubMed ID: 24497345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of exercise training on mobilization of BM-CPCs and migratory capacity as well as LVEF after AMI].
    Turan RG; Brehm M; Köstering M; Bartsch T; Zeus T; Picard F; Steiner S; Fleissner T; Ilousis D; Augusta K; Kister M; Rüttger C; Schannwell CM; Strauer BE
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():198-201. PubMed ID: 16802555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exercise training on mobilization and functional activity of blood-derived progenitor cells in patients with acute myocardial infarction.
    Brehm M; Picard F; Ebner P; Turan G; Bölke E; Köstering M; Schüller P; Fleissner T; Ilousis D; Augusta K; Peiper M; Schannwell Ch; Strauer BE
    Eur J Med Res; 2009 Sep; 14(9):393-405. PubMed ID: 19748858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype of peripheral blood cells mobilized by granulocyte colony-stimulating factor in patients with chronic heart failure.
    Konenkov VI; Pokushalov EA; Poveshchenko OV; Kim II; Romanov AB; Guleva NA; Bernvald VV; Soloviova AO; Yankayte EV; Poveshchenko AF; Karaskov AM
    Bull Exp Biol Med; 2012 May; 153(1):124-8. PubMed ID: 22808510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction.
    Ascione R; Rowlinson J; Avolio E; Katare R; Meloni M; Spencer HL; Mangialardi G; Norris C; Kränkel N; Spinetti G; Emanueli C; Madeddu P
    Stem Cell Res Ther; 2015 Apr; 6(1):53. PubMed ID: 25889213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased number of circulating progenitor cells after implantation of ventricular assist devices.
    Manginas A; Tsiavou A; Sfyrakis P; Giamouzis G; Tsourelis L; Leontiadis E; Degiannis D; Cokkinos DV; Alivizatos PA
    J Heart Lung Transplant; 2009 Jul; 28(7):710-7. PubMed ID: 19560700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous mesenchymal stem cells mobilize cKit+ and CD133+ bone marrow progenitor cells and improve regional function in hibernating myocardium.
    Suzuki G; Iyer V; Lee TC; Canty JM
    Circ Res; 2011 Oct; 109(9):1044-54. PubMed ID: 21885831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COMPARE-AMI trial: comparison of intracoronary injection of CD133+ bone marrow stem cells to placebo in patients after acute myocardial infarction and left ventricular dysfunction: study rationale and design.
    Mansour S; Roy DC; Bouchard V; Nguyen BK; Stevens LM; Gobeil F; Rivard A; Leclerc G; Reeves F; Noiseux N
    J Cardiovasc Transl Res; 2010 Apr; 3(2):153-9. PubMed ID: 20560029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating CD133+ CD34+ progenitor cells and plasma stromal-derived factor-1alpha: predictive role in ischemic stroke patients.
    Chen Y; Lu B; Wang J; Chen S; Lin Z; Ma X; Liu Y; Zhao B; Chen Y
    J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):319-26. PubMed ID: 25444027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial blood flow and infarct size after CD133+ cell injection in large myocardial infarction with good recanalization and poor reperfusion: results from a randomized controlled trial.
    Colombo A; Castellani M; Piccaluga E; Pusineri E; Palatresi S; Longari V; Canzi C; Sacchi E; Rossi E; Rech R; Gerundini P; Viecca M; Deliliers GL; Rebulla P; Soligo D; Giordano R
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):239-48. PubMed ID: 21372740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.